Table 5.
The testing results of common biomarkers
| Sample | GJJ.T0_WES | KZP.T0_WES | LLL.T0_WES | MRH.T0_WES | MXW.T0_WES | MYT.T0_WES | WHX.T0_WES | ZWY.T0_WES |
|---|---|---|---|---|---|---|---|---|
| DDR | – | – | – | – | – | – | – | BRIP1, p. Ile1209Met |
| TMB | TMB-L:1.35 | TMB-M:3.45 | TMB-L:1.12 | TMB-L:1.73 | TMB-M:3.07 | TMB-L:1.91 | TMB-L:1.43 | TMB-L:1.32 |
| TNB | TNB-M:0.72 | TNB-M:1.13 | TNB-L:0.44 | TNB-M:0.63 | TNB-M:1.53 | TNB-M:0.72 | TNB-M:0.69 | TNB-L:0.31 |
| MSI | 4.69 | 0.9 | 1.71 | 2.56 | 2.7 | 4.11 | 7.19 | 5.74 |
| HLA mutation | – | – | – | – | – | – | – | – |
| B2M mutation | – | – | – | – | – | – | – | – |
| ALK fusion | – | – | – | – | – | – | – | – |
| EGFR mutation | – | – | – | – | – | – | – | – |
| JAK1/2 mutation | – | – | – | – | – | – | – | – |
| PTEN mutation | – | – | – | – | – | – | – | – |
| STK11mutation | – | – | – | – | STK11, p. Met18Ile | – | – | – |
| MDM2 amplification | – | MDM2, amp8 | – | – | – | – | – | – |
| MDM4 amplification | – | – | – | – | – | – | – | – |
| DNMT3A mutation | – | – | – | – | – | – | – | – |
| HLA-LOH | HLA-A*30:01 | |||||||
| HLA-C*03:03 | – | – | – | HLA-A*24:02 | ||||
| HLA-C*01:02 | – | – | – |